AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback.

For instance, in a case study, AI-enabled personalisation was used to support patients on an anticoagulant medication, which led to an 18.8% increase in days on therapy. Commitment to continuous ...

WebMD’s Pill Identifier can help you put a name to an unknown medication. It identifies prescription and over-the-counter (OTC) meds that you take in solid form by mouth, like tablets and capsules.

Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.